UPDATE: Jefferies Upgrades Walgreen Company to Buy on Purchasing Synergies
Jefferies raised its rating on Walgreen Company (NYSE: WAG) from Hold to Buy and increased its price target from $40 to $47.
Jefferies said, "We are upgrading WAG to Buy from Hold as our research continues to suggest that purchasing synergies are materializing faster than expected. In addition, the potential for higher script volumes (Flu/Med D/ObamaCare) could also drive better profitability. With valuation at the low-end of its range and at roughly a 2x P/E discount to CVS, investors could be rewarded with both EPS surprises and multiple expansion over the next 12 months."
Walgreen Company closed at $37.18 on Friday.
Latest Ratings for WAG
|Dec 2014||JP Morgan||Maintains||Overweight|
|Dec 2014||SunTrust Robinson Humphrey||Downgrades||Buy||Neutral|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.